Up to 50% of people with bipolar disorder attempt suicide over their lifetime, and estimates indicate that up to 20% may succumb to suicide. NRx, an American pharmaceutical company co-founded by Israeli citizens Jonathan Javitt, MD, and Daniel Javitt, MD, is aiming to significantly reduce these figures by developing therapeutics for the treatment of central nervous system disorders, specifically suicidal depression and post-traumatic stress disorder (PTSD).NRx has announced that it has begun trials on a new medication that significantly reduces the risk of suicidality in Biopolar Disorder.

https://www.calcalistech.com/ctechnews/article/b1kv2lfwo

#calcalistech